Ballad Health’s credit rating affirmed by Moody’s

Despite numerous health systems recently receiving credit downgrades, Ballad Health is not one of those on the list.

Rather, it’s had its credit rating affirmed. Ballad announced Thursday that Moody’s Investors Service affirmed its BAA1 revenue bond rating for the company, while also giving the health care company a positive outlook. Standard and Poor’s credit rating was also great news for Ballad, as it gave the company an A- last November.

“With such serious headwinds for non-urban and rural health systems, we are proud that Moody’s has recognized the hard work of our board, our team members and our physicians as we seek to deliver high quality care at a lower cost,“ said Ballad Health Chairman and CEO Alan Levine.

Ballad has released its second quarter results, showing the company’s commitment to cost savings for patients, taxpayers, and employers, while reporting stable financial performance amid significant challenges.